Drug intelligence / Profile preview

baicalin aluminum

Development stage
Unknown
Lead developer
Third Military Medical University
Modality
Small Molecules
Administration
Oral
01

Overview

Baicalin aluminum is a metal-organic coordination complex consisting of baicalin, a flavonoid extracted from Radix Scutellariae (Scutellaria baicalensis), and aluminum ions. Developed by the State Key Laboratory of Trauma, Burns, and Combined Injury at the Third Military Medical University (Daping Hospital), this drug is designed to treat sepsis and severe infections by targeting bacterial endotoxins. Its primary mechanism involves binding to the Lipid A component of lipopolysaccharide (LPS), which neutralizes the endotoxin and prevents it from triggering the TLR4-mediated inflammatory cascade. This action helps mitigate the systemic inflammatory response syndrome (SIRS) and multi-organ dysfunction associated with sepsis. The drug has been investigated in clinical trials in China as a novel anti-endotoxin therapy.

Other names
radix scutellariae aluminum capsulesaluminum baicalinScutellaria baicalensis aluminum capsulesbaicalin aluminum capsules

Beyond the preview

Go deeper on baicalin aluminum.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on baicalin aluminum.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call